ArticleChemistryOpen2021
Bimetallic Pd/Sn-based Nanoparticles and their Catalytic Properties in the Semihydrogenation of Diphenylacetylene.
Article in ChemistryOpen, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Multimetallic nanoparticles often enhance the catalytic performance of their monometallic counterparts by increasing reaction rates, catalyst selectivity, and/or stability. A prerequisite for understanding structure- and composition-associated properties, however, is the careful design of multimetallic nanoparticles with various structures and compositions. Here, bimetallic Pd/Sn-based nanoparticles are prepared with a tunable composition and structure exploiting ionic liquids (ILs) as reaction medium (i. e., methyltrioctylammonium bis(trifluoromethylsulfonyl)imide). The nanoparticles are obtained in a one-pot synthetic procedure by reducing the metal salt precursors with triethylborohydride in the IL. The results show that the reaction parameters, in particular the nature and ratio of the Pd
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.